Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Recurrent nasopharyngeal cancer"'
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-11 (2016)
Abstract Background After definitive chemoradiotherapy for non-metastatic nasopharyngeal carcinoma (NPC), more than 10% of patients will experience a local recurrence. Salvage treatments present significant challenges for locally recurrent NPC. Surge
Externí odkaz:
https://doaj.org/article/4037a4a392ba41c78a0312f9df58011b
Autor:
Yu-Wei Lin, Hsiu-Wen Ho, Hsiao-Yun Chen, Shih-Chang Wang, Hsiu-Man Lin, Chun-Chiao Huang, Ching-Chieh Yang
Publikováno v:
Medical Dosimetry. 46:164-170
The purpose of this study was to evaluate the feasibility and efficacy of HyperArc (HA) for recurrent nasopharyngeal cancer (NPC) by comparing it with the CyberKnife system (CK). Fifteen patients with recurrent nasopharyngeal cancer who were treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b87e5d1a78ff98c5121cd6b85a242ff9
https://doi.org/10.1016/j.meddos.2020.10.007
https://doi.org/10.1016/j.meddos.2020.10.007
Publikováno v:
Head & Neck. 42:3415-3426
Consensus has yet to be reached on the optimal operation for patients with residual or recurrent nasopharyngeal carcinoma (NPC). To compare effectiveness and safety of open surgery and endoscopic surgery for patients with residual or recurrent NPC. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2eff47150501ac638de48fe839b3352
https://doi.org/10.1002/hed.26397
https://doi.org/10.1002/hed.26397
Autor:
Švajdová Michaela
Publikováno v:
5. konferencia Slovenskej spoločnosti radiačnej onkológie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3253::e6ab92f20e9b4b75f2ea64d2419cd665
https://is.muni.cz/publication/1855897
https://is.muni.cz/publication/1855897
Publikováno v:
HeadneckREFERENCES. 43(12)
Despite advances in the treatment of primary nasopharyngeal carcinoma, locoregional recurrence (lrNPC) occurs at 10%-50% at 5 years. This review aims to evaluate salvage treatment for locally recurrent nasopharyngeal cancer. A literature search for a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd0e09f7d3187ec11e1998434935784c
https://pubmed.ncbi.nlm.nih.gov/34403174
https://pubmed.ncbi.nlm.nih.gov/34403174
Autor:
Lin Kong, Jiade J. Lu
Publikováno v:
Practical Guides in Radiation Oncology ISBN: 9783030650360
The prevailing use of intensity-modulated radiation therapy (IMRT) and the concurrent chemoradiotherapy strategy have significantly improved treatment outcomes of nonmetastatic nasopharyngeal cancer (NPC). However, approximately 10–15% of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bd90d5b566a5a222624a00f7c3cccf9
https://doi.org/10.1007/978-3-030-65037-7_8
https://doi.org/10.1007/978-3-030-65037-7_8
Publikováno v:
Cancers
Simple Summary Options for the curative treatment of locally recurrent nasopharyngeal carcinoma include surgery or re-irradiation. Both approaches have been scientifically explored, yet there is no consensus on the indication or definitive preference
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2392d95bca119af69cecc994ccff65ab
http://europepmc.org/articles/PMC7760235
http://europepmc.org/articles/PMC7760235
Autor:
Jason Y. K. Chan, Kai-Ping Chang, Raymond K. Y. Tsang, Kimberley Liqin Kiong, Constance Teo, Chih-Yen Chien, Jimmy Yu Wai Chan, Sheng-Po Hao, Clarisse Chu, Eddy W.Y. Wong, Chwee Ming Lim, Mingyuan Chen, Anna See, Hiang Khoon Tan
Publikováno v:
Oral Oncology. 122:105556
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::919173d23c26439fa0190f2e329abb3e
https://doi.org/10.1016/j.oraloncology.2021.105556
https://doi.org/10.1016/j.oraloncology.2021.105556
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Cancer
Background: Radiation therapy is the mainstay strategy for the treatment of nasopharyngeal cancer (NPC). Intensity-modulated X-ray therapy (IMXT) alone is the current standard for stage I and II NPC. For stage III and IV A/B diseases, concurrent chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ebb16e23c39196a29c218724e065b8c
https://doi.org/10.7150/jca.14399
https://doi.org/10.7150/jca.14399